The development of USP botanical dietary supplement monographs, 1995-2005

Journal of Natural Products

Volumn 69, Issue 3, 2006, Pages 464-472

  Schiff Jr , Paul L ^a   Srinivasan, V Srini ^b   Giancaspro, Gabriel I ^b   Roll, David B ^b   Salguero, Jennifer ^b   Sharaf, Maged H M ^b  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b UNITED STATES PHARMACOPEIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BOTANY; DIET SUPPLEMENTATION; DRUG FORMULARY; GOOD MANUFACTURING PRACTICE; HISTORY OF MEDICINE; MEDICAL PRACTICE; PUBLICATION; REVIEW;

DIETARY SUPPLEMENTS; HUMANS; PHARMACOPOEIAS; PHYTOTHERAPY; UNITED STATES;

EID: 33645976727     PISSN: 01633864     EISSN: None     Source Type: Journal    
DOI: 10.1021/np0581061     Document Type: Review

References (72)

1. Anderson, L. A.; Higby, G. J. The Spirit of Voluntarism; The United States Pharmacopeial Convention, Inc.: Rockville, MD, 1995; 598 pp.
2. The United States Pharmacopeia 28/The National Formulary 23; The United States Pharmacopeial Convention, Inc.: Rockville, MD, 2005; pp v-xii.
3. Bhattacharyya, L.; Cecil, T.; Dabbah, R.; Roll, D.; Schuber, Sheinin, E. B.; Williams, R. L.; Boehlert, J. P.; Cohen, E. M.; DeMuth, J. E.; Frederiksen, M. C.; Klein, H. G.; Russell, R. M.; Schiff, P. L., Jr.; Seaver, S. S.; Shepherd, A. M. M.; Stavchansky, S.; Wozniak, T. J. Pharm. Res. 2004, 21, 1725-1731.
4. Proceedings of the USP Open Conference on Dietary Supplements: Current Issues on Quality and Evidence Supporting Claims; Los Angeles, August 16-18, 1998; The United States Pharmacopeial Convention, Inc.: Rockville, MD, 1998.
5. Swan, G. B. An Introduction to the Alkaloids; John Wiley & Sons: New York, 1967; pp 61-141.
6. The United States Pharmacopeia 23/The National Formulary 18; The United States Pharmacopeial Convention, Inc.: Rockville, MD, 1995; pp 15-1647; 2209-2320.
7. The United States Pharmacopeia 28/The National Formulary 23; The United States Pharmacopeial Convention, Inc.: Rockville, MD, 2005; pp 13-2058; 2947-3110.
8. Blumenthal, M. HerbalGram 1994, 32, 18-20.
9. The Spirit of Voluntarism: Proceedings of the United States Pharmacopeial Convention; Washington, DC, March 9-12, 1995; The United States Pharmacopeial Convention, Inc.: Rockville, MD, 1995; pp 267-279; 409.
10. Srinivasan, V. S.; Kucera, P. In Proceedings of the USP Open Conference on Dietary Supplements: Current Issues on Quality and Evidence Supporting Claims; Los Angeles, August 16-18, 1998; The United States Pharmacopeial Convention, Inc.: Rockville, MD, 1998; p. 22-24.
11. Elected Members of this Subcommittee included Paul J. Kucera (Chair) (Wyeth-Ayerst), Edward M. Croom (The University of Mississippi), David Katague (CDER/FDA), Edward G. Lovering (Private Consultant), Samuel W. Page (Division of Natural Products/ FDA), Paul L. Schiff, Jr. (University of Pittsburgh), and E. John Staba (University of Minnesota). The USP Staff Liaison was V. Srini Srinivasan, Senior Scientist, Natural Products (NAT).
12. Individuals who served on the appointed Advisory Panel to the Subcommittee were Dennis V. C. Awang (Mediplant), Ezio Bombardelli (Indena), Werner Busse (Schwabe Pharmaceuticals), Horace G. Cutler (Mercer University), Jonathan W. DeVries (Medallion Laboratories), Patrick Dunn (Leiner Health Products), Gary W. Elmer (University of Washington), Forouz Ertl (Technical Botanicals International), Patrick Hoffman (McCormick & Company), Charles D. Hufford (The University of Mississippi), Michael Ihrig (Zentrallaboratorium Deutscher Apotheker), A. Douglas Kinghorn (University of Illinois at Chicago), Nahid Mokhtari-Rejali (Division of OTC Products/FDA), William Popin (Nature's Herbs), Amala Raman (King's College, London), Walter Schulze (ACTA Laboratories), and Sidney J. Stohs (Creighton University).
13. The Members of 2000-2005 Committee of Experts included Paul L. Schiff, Jr. (Chair) (University of Pittsburgh), Joseph M. Betz (2004-2005) (Office of Dietary Supplements, National Institutes of Health), Yuan-yuan Chiu (2000-2003) (Center for Drug Evaluation and Research, Food and Drug Administration), Forouz S. Ertl (2000) (Botanicals International/Hauser), Dennis Gorecki (University of Saskatchewan), Norman R. Farnsworth (University of Illinois at Chicago), Paul J. Kucera (Wyeth Pharmaceuticals), Samuel W. Page (2000-2004) (World Health Organization), William Popin (Young Living Essential Oils), Fabio Soldati (Pharmaton, Switzerland), and Otto Sticher (Swiss Federal Institute of Technology).
14. Individuals who served on the appointed Advisory Panel to the Committee included William Popin (Chair) (Young Living Essential Oils), Rudolf Bauer (Karl Franzens University, Graz), Mark Blumenthal (American Botanical Council), Ezio Bombardelli (Indena, Italy), John Cardellina (National Cancer Institute), Edward Fletcher (Strategic Sourcing), James S. Miller (Missouri Botanical Garden), Simon Y. Mills (University of Exeter), Gregory Pennyroyal (Growin Medicine), Amala Raman (King's College London), Kathy Sharpless (NIST), and Roy Upton (American Herbal Pharmacopeia).
15. The United States Pharmacopeia 28/The National Formulary 23; The United States Pharmacopeial Convention, Inc.: Rockville, MD, 2005; pp 1-12.
16. The United States Pharmacopeia 28/The National Formulary 23; The United States Pharmacopeial Convention, Inc.: Rockville, MD, 2005; pp 4-5; 2184-2790.
17. The United States Pharmacopeia 28/The National Formulary 23; The United States Pharmacopeial Convention, Inc.: Rockville, MD, 2005; pp 2338-2345.
18. The United States Pharmacopeia 28/The National Formulary 23; The United States Pharmacopeial Convention, Inc.: Rockville, MD, 2005; pp 2345-2352.
19. The United States Pharmacopeia 26/The National Formulary 21; The United States Pharmacopeial Convention, Inc.: Rockville, MD, 2003; pp 2092-2098.
20. The United States Pharmacopeia 28/The National Formulary 23; The United States Pharmacopeial Convention, Inc.: Rockville, MD, 2005; pp 2352-2353.
21. The United States Pharmacopeia 25/The National Formulary 20; The United States Pharmacopeial Convention, Inc.: Rockville, MD, 2002; pp 1958-1959.
22. Anonymous. Pharm. Forum 2005, 31, 559-572.
23. The United States Pharmacopeia 28/The National Formulary 23; The United States Pharmacopeial Convention, Inc.: Rockville, MD, 2005; pp 2781-2790.
24. Webster's New Collegiate Dictionary; G. & C. Merriam Company: Springfield, MA, 1980; p 738.
25. Schiff, P. L., Jr.; Srinivasan, V. S. J. Herbal Pharmacother. 2001, 1, 1-29.
26. McGuffin, M.; Kartesz, J. T.; Leung, A. Y.; Tucker, A. O. Herbs of Commerce, 2nd ed.; American Herbal Products Association: Silver Spring, MD, 2000; 421 pp.
27. The United States Pharmacopeia 28/The National Formulary 23; The United States Pharmacopeial Convention, Inc.: Rockville, MD, 2005; pp 2087-2091.
28. The United States Pharmacopeia 28/The National Formulary 23; The United States Pharmacopeial Convention, Inc.: Rockville, MD, 2005; pp 2091-2094.
29. The United States Pharmacopeia 28/The National Formulary 23; The United States Pharmacopeial Convention, Inc.: Rockville, MD, 2005; pp 2107-2108.
30. The United States Pharmacopeia 28/The National Formulary 23; The United States Pharmacopeial Convention, Inc.: Rockville, MD, 2005; pp 2116-2119.
31. The United States Pharmacopeia 28/The National Formulary 23; The United States Pharmacopeial Convention, Inc.: Rockville, MD, 2005; pp 2126-2130.
32. The United States Pharmacopeia 28/The National Formulary 23; The United States Pharmacopeial Convention, Inc.: Rockville, MD, 2005; pp 2105-2107.
33. The United States Pharmacopeia 28/The National Formulary 23; The United States Pharmacopeial Convention, Inc.: Rockville, MD, 2005; pp 2081-2083.
34. The United States Pharmacopeia 28/The National Formulary 23; The United States Pharmacopeial Convention, Inc.: Rockville, MD, 2005; pp 2080-2081.
35. The United States Pharmacopeia 28/The National Formulary 23; The United States Pharmacopeial Convention, Inc.: Rockville, MD, 2005; pp 2075-2078.
36. The United States Pharmacopeia 28/The National Formulary 23; The United States Pharmacopeial Convention, Inc.: Rockville, MD, 2005; pp 2078-2079.
37. The United States Pharmacopeia 28/The National Formulary 23; The United States Pharmacopeial Convention, Inc.: Rockville, MD, 2005; pp 2062-2136.
38. Anonymous. Pharm. Forum 2002, 28, 1455-1463.
39. The United States Pharmacopeia 28/The National Formulary 23; The United States Pharmacopeial Convention, Inc.: Rockville, MD, 2005; pp 2086-2087.
40. The United States Pharmacopeia 28/The National Formulary 23; The United States Pharmacopeial Convention, Inc.: Rockville, MD, 2005; pp 2124-2126.
41. The United States Pharmacopeia 28/The National Formulary 23; The United States Pharmacopeial Convention, Inc.: Rockville, MD, 2005; pp 2109-2110.
42. The United States Pharmacopeia 28/The National Formulary 23; The United States Pharmacopeial Convention, Inc.: Rockville, MD, 2005; pp 2064-2066.
43. The United States Pharmacopeia 28/The National Formulary 23; The United States Pharmacopeial Convention, Inc.: Rockville, MD, 2005; p 2074.
44. The United States Pharmacopeia 28/The National Formulary 23; The United States Pharmacopeial Convention, Inc.: Rockville, MD, 2005; pp 2095-2098.
45. The United States Pharmacopeia 28/The National Formulary 23; The United States Pharmacopeial Convention, Inc.: Rockville, MD, 2005; pp 2103-2105.
46. The United States Pharmacopeia 28/The National Formulary 23; The United States Pharmacopeial Convention, Inc.: Rockville, MD, 2005; pp 2094-2095.
47. The United States Pharmacopeia 28/The National Formulary 23; The United States Pharmacopeial Convention, Inc.: Rockville, MD, 2005; pp 2071-2073.
48. The United States Pharmacopeia 28/The National Formulary 23; The United States Pharmacopeial Convention, Inc.: Rockville, MD, 2005; pp 5; 2204-2233.
49. The United States Pharmacopeia 28/The National Formulary 23; The United States Pharmacopeial Convention, Inc.: Rockville, MD, 2005; pp 2133-2136.
50. The United States Pharmacopeia 28/The National Formulary 23; The United States Pharmacopeial Convention, Inc.: Rockville, MD, 2005; pp 2098-2100.
51. Trease, G. E.; Evans, W. C. Pharmacognosy, 12th ed.; Baillière Tindall: London, 1983; pp 130-146.
52. The United States Pharmacopeia 28/The National Formulary 23; The United States Pharmacopeial Convention, Inc.: Rockville, MD, 2005; pp 2114-2116.
53. The United States Pharmacopeia 28/The National Formulary 23; The United States Pharmacopeial Convention, Inc.: Rockville, MD, 2005; pp 2062-2064.
54. The United States Pharmacopeia 28/The National Formulary 23; The United States Pharmacopeial Convention, Inc.: Rockville, MD, 2005; p 2429.
55. The United States Pharmacopeia 28/The National Formulary 23; The United States Pharmacopeial Convention, Inc.: Rockville, MD, 2005; pp 2510-2513.
56. Anonymous. Pharm. Forum 2004, 30, 1071-1080.
57. The United States Pharmacopeia 28/The National Formulary 23; The United States Pharmacopeial Convention, Inc.: Rockville, MD, 2005; pp 2083-2085.
58. The United States Pharmacopeia 28/The National Formulary 23, First Supp.; The United States Pharmacopeial Convention, Inc.: Rockville, MD, 2005; pp 3287-3289.
59. The United States Pharmacopeia 28/The National Formulary 23; The United States Pharmacopeial Convention, Inc.: Rockville, MD, 2005; pp 2299-2300.
60. The United States Pharmacopeia 28/The National Formulary 23; The United States Pharmacopeial Convention, Inc.: Rockville, MD, 2005; pp 2322-2332.
61. Anonymous. Pharm. Forum 2005, 31, 1435-1447.
62. The United States Pharmacopeia 28/The National Formulary 23; The United States Pharmacopeial Convention, Inc.: Rockville, MD, 2005; pp 2768-2770.
63. The United States Pharmacopeia 28/The National Formulary 23; The United States Pharmacopeial Convention, Inc.: Rockville, MD, 2005; pp 2246-2251.
64. The United States Pharmacopeia 28/The National Formulary 23; The United States Pharmacopeial Convention, Inc.: Rockville, MD, 2005; pp 2771-2775.
65. The United States Pharmacopeia 28/The National Formulary 23; The United States Pharmacopeial Convention, Inc.: Rockville, MD, 2005; pp 2775-2777.
66. Anonymous. Pharm. Forum 2005, 31, 985-996.
67. Anonymous. Pharm. Forum 2003, 29, 19-20; 374-375; 584-585.
68. Anonymous. Pharm. Forum 2004, 30, 554-555.
69. Anonymous. Pharm. Forum 2004, 30, 556-557.
70. Anonymous. Pharm. Forum 2004, 30, 561-563.
71. Anonymous. Pharm. Forum 2004, 30, 574.
72. Anonymous. Pharm. Forum 2004, 30, 584-585.